Adipose Derived Mesenchymal Stem Cell Secretome Formulation as a Biotherapeutic to Inhibit Growth of Drug Resistant Triple Negative Breast Cancer

Researchers developed a protocol for processing human adipose derived MSC secretome formulation of varying concentration. Its molecular composition was evaluated, and its effectiveness in vitro using breast cancer cell lines.